Development of a strategic model for integrating complementary medicines into professional pharmacy practice

Background: Traditional medicine (TM) and complementary medicine (CM) products have played an increasingly important role in the business of pharmacy for over two decades in a number of countries. With a focus on the quality use of all medicines including complementary medicines, there have been a number of initiatives to encourage the integration of TM/CM products into professional practice. Recent studies report that many of the barriers that prevent such integration remain. Objectives: To explore the pharmacists' perspective regarding how barriers to the integration of TM/CM products into the professional practice of pharmacy could be resolved. Methods: Purposive sampling and snowballing were used to recruit 11 registered pharmacists who had worked in community pharmacy for a minimum of 6 months to participate in one of 3 focus groups. Focus group questions informed by previous studies, explored participants' perspectives on the actions required to support professional services related to TM/CM products. Results: Pharmacists proposed that five key stakeholders (professional pharmacy organizations, universities, government, pharmacy owners, and pharmacists) enact 4 developments that require a collaborative effort (education and training, building the evidence base, developing reliable and accessible information resources, and workplace support for best practice). Manufacturers of TM/CM products were not identified by pharmacists as collaborators in these developments. Conclusion: Collectively, the findings from this study support a strategic model to guide the integration of TM/CM products into the professional practice of pharmacy. (C) 2017 Elsevier Inc. All rights reserved.